Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1980-11-25
pubmed:abstractText
Rat-1 cells were transfected with the restriction enzyme fragment of polyoma virus DNA that extends clockwise from the Bcl I site ((65.4 map units) to the EcoRI site (0/100 map units). Six transformed cell lines were obtained and one of them (BE-1) has been investigated in detail. The viral DNA that is integrated into host DNA in this line appeared to consist of two fragments arranged in a "head-to-tail" tandem with no detectable intervening host sequences. BE-1 cells contained polyoma virus small and middle tumor antigens that were indistinguishable from the corresponding tumor antigens from lytically infected cells. No large tumor antigen was detected but a "new" Mr 34,000 protein, which proved to be a truncated version of large tumor antigen, was immunoprecipitated by anti-tumor-antigen antiserum. After injection of 10(6) BE-1 cells into young syngeneic Fischer rats, tumors appeared within 3--4 weeks. Thus, the coding capacity of the Bcl I/EcoRI fragment of polyoma virus DNA is sufficient to enable the cells to produce all of small and middle tumor antigens and about a third of large tumor antigen, to transform cells stably in culture, and to produce tumors in vivo.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/6251451-1195397, http://linkedlifedata.com/resource/pubmed/commentcorrection/6251451-169059, http://linkedlifedata.com/resource/pubmed/commentcorrection/6251451-169088, http://linkedlifedata.com/resource/pubmed/commentcorrection/6251451-169096, http://linkedlifedata.com/resource/pubmed/commentcorrection/6251451-175289, http://linkedlifedata.com/resource/pubmed/commentcorrection/6251451-186787, http://linkedlifedata.com/resource/pubmed/commentcorrection/6251451-193254, http://linkedlifedata.com/resource/pubmed/commentcorrection/6251451-193256, http://linkedlifedata.com/resource/pubmed/commentcorrection/6251451-198573, http://linkedlifedata.com/resource/pubmed/commentcorrection/6251451-201774, http://linkedlifedata.com/resource/pubmed/commentcorrection/6251451-212199, http://linkedlifedata.com/resource/pubmed/commentcorrection/6251451-215327, http://linkedlifedata.com/resource/pubmed/commentcorrection/6251451-219251, http://linkedlifedata.com/resource/pubmed/commentcorrection/6251451-222480, http://linkedlifedata.com/resource/pubmed/commentcorrection/6251451-225038, http://linkedlifedata.com/resource/pubmed/commentcorrection/6251451-225866, http://linkedlifedata.com/resource/pubmed/commentcorrection/6251451-226975, http://linkedlifedata.com/resource/pubmed/commentcorrection/6251451-229246, http://linkedlifedata.com/resource/pubmed/commentcorrection/6251451-4134493, http://linkedlifedata.com/resource/pubmed/commentcorrection/6251451-4200179, http://linkedlifedata.com/resource/pubmed/commentcorrection/6251451-4291934, http://linkedlifedata.com/resource/pubmed/commentcorrection/6251451-4314508, http://linkedlifedata.com/resource/pubmed/commentcorrection/6251451-4353950, http://linkedlifedata.com/resource/pubmed/commentcorrection/6251451-4354250, http://linkedlifedata.com/resource/pubmed/commentcorrection/6251451-4365585, http://linkedlifedata.com/resource/pubmed/commentcorrection/6251451-4737663, http://linkedlifedata.com/resource/pubmed/commentcorrection/6251451-6243401, http://linkedlifedata.com/resource/pubmed/commentcorrection/6251451-6243821, http://linkedlifedata.com/resource/pubmed/commentcorrection/6251451-73183, http://linkedlifedata.com/resource/pubmed/commentcorrection/6251451-795607, http://linkedlifedata.com/resource/pubmed/commentcorrection/6251451-881736
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:volume
77
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3278-82
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1980
pubmed:articleTitle
Coding capacity of a 35 percent fragment of the polyoma virus genome is sufficient to initiate and maintain cellular transformation.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't